Influence of cosolvents, ionic strength and the method of sample preparation on the solubilization of curcumin by Pluronics and HP-γ-cyclodextrin: Studies of curcumin and curcuminoids, XLIV

Pharmazie

Volumn 67, Issue 2, 2012, Pages 131-142

  Singh, Ravinder ^a   Kristensen, S ^a   Tonnesen H H ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL GAMMA CYCLODEXTRIN; CURCUMIN; GAMMA CYCLODEXTRIN DERIVATIVE; MACROGOL 400; POLOXAMER; PROPYLENE OXIDE; UNCLASSIFIED DRUG; HYDROXYPROPYL GAMMA CYCLODEXTRIN; HYDROXYPROPYL-GAMMA-CYCLODEXTRIN; SOLVENT;

ARTICLE; CRITICAL MICELLE CONCENTRATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STRUCTURE; IONIC STRENGTH; PRECIPITATION; SCANNING ELECTRON MICROSCOPY; ADSORPTION; CALIBRATION; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY DIAGNOSIS; MICELLE; MOLECULAR WEIGHT; OSMOLARITY; REPRODUCIBILITY; SOLUBILITY; STANDARD;

ADSORPTION; CALIBRATION; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMIN; GAMMA-CYCLODEXTRINS; MICELLES; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; POLOXAMER; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SOLVENTS; SPECIMEN HANDLING;

EID: 84860635484     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1097     Document Type: Article

References (44)

1. Alexandridis P, Holzwarth JF, Hatton TA (1994) Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association. Macromolecules 27: 2414-2425.
2. Aliabadi HM, Lavasanifar A. (2006) Polymeric micelles for drug delivery. Expert Opin Drug Deliv 3: 139-162.
3. Armstrong J, Chowdhry B, Mitchell J, Beezer A, Leharne S (1996) Effect of cosolvents and cosolutes upon aggregation transitions in aqueous solutions of the Poloxamer F87 (Poloxamer P237): a high sensitivity Differential Scanning Calorimetry study. J Phys Chem 100: 1738-1745.
4. BASF (2011) Pluronic® http://worldaccount.basf.com/wa/NAFTA~en-US/ Catalog/ChemicalsNAFTA/pi/BASF/Brand/pluronic.
5. BASF (2009) Pluronic® grid. http://www2.basf.us/performancechemical/ bcperfpluronic grid.html.
6. BASF (2010) Nomenclature and the Pluronic® Surfactant Grid. http://www2.basf.us/performancechemical/bcperfnomenclature.html.
7. Brewster ME, Vandecruys R, Peeters J, Neeskens P, Verreck G, Loftsson T (2008) Comparative interaction of 2-hydroxypropyl-beta -cyclodextrin and sulfobutylether-beta -cyclodextrin with itraconazole: Phase-solubility behavior and stabilization of supersaturated drug solutions. Eur J Pharm Sci 34: 94-103.
8. Brouwers J, Brewster ME, Augustijns P (2009) Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability? J Pharm Sci 98: 2549-2572.
9. Chen LX, He YJ, Zhao SZ, Wu JG, Wang JT, Zhu LM, Lin TT, Sun BC, Li XR. (2011) Inhibition of tumor growth and vasculogenic mimicry by curcumin through downregulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer Biol Ther 11: 229-235.
10. Curatolo W, Nightingale JA, Herbig SM (2009) Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI Milieu. Pharm Res 26: 1419-1431.
11. Das RK, Kasoju N, Bora U (2010) Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 6: 153-160.
12. Desai PR, Jain NJ, Sharma RK, Bahadur P (2001) Effect of additives on the micellization of PEO/PPO/PEO block copolymer F127 in aqueous solution. Colloids Surf A 178: 57-69.
13. FDA (2009) Inactive Ingredient search for approved drug products. http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
14. Florence A, et al. (1998) Properties of the Solid State. In: Florence A, Attwood D (ed.) Physiochemical principles of pharmacy, 3 ed., Hampshire: Palgrave, pp. 5-35.
15. Gardikis K, Dimas K, Georgopoulos A, Kaditi E, Pispas S, Demetzos C (2010) Beta-lactam functionalized poly(isoprene-b-ethylene oxide) amphiphilic block copolymer micelles as a new nanocarrier system for curcumin. Curr Nanosci 6: 277-284.
16. GuideChem (2011) CAS NO. 99241-25-5. http://www.guidechem.com/cas-992/ 99241-25-5.html.
17. Guzman HR, Tawa M, Zhang Z, Ratanabanangkoon P, Shaw P, Gardner CR, Chen H, Moreau JP, Almarsson O, Remenar JF (2007) Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. J Pharm Sci 96: 2686-2702.
18. Hioka N, Chowdhary RK, Chansarkar N, Delmarre D, Sternberg E, Dolphin D (2002) Studies of a benzoporphyrin derivative with pluronics. Can J Chem 80: 1321-1326.
19. Ho HO, Chen CN, Sheu MT (2000) Influence of pluronic F-68 on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery. J Control Release 68: 433-440.
20. Jansook P, Kurkov SV, Loftsson T (2010) Cyclodextrins as solubilizers: formation of complex aggregates. J Pharm Sci 99: 719-729.
21. Kabanov AV, Batrakova EV, Alakhov VY (2002) Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Controlled Release 82: 189-212.
22. Kabanov AV, Alakhov VY (2002) Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst 19 (1): 1-72.
23. Letchford K, Liggins R, Burt H (2008) Pharmaceutics, preformulation and drug delivery. J Pharm Sci 97: 1179-1190.
24. Loftsson T, Masson M, Sigurjonsdottir JF (1999) Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma Sci 9: 237-242.
25. Ma ZS, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J (2008) Micelles of poly(ethylene oxide)-b-poly(e-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res Part A 86A: 300-310.
26. Myrdal P, Yalkowsky SH (2002) Solubilization of drugs in aqueous media. In: Swarbick J, Boylan, JC (ed.) Encyclopedia of pharmaceutical technologyl, 2 ed., New York: Marcel Dekker, 2458-2480.
27. Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto, EB (2010) Curcuminoids-loaded lipid nanoparticles: Novel approach towards malaria treatment. Colloids Surf B 81: 263-273.
28. Oh DH, Park YJ, Kang JH, Yong CS, Choi HG (2011) Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Drug Deliv 18: 46-53.
29. Pabon HJJ (1964) Synthesis of Curcumin and Related Compounds. Recl.: J R Neth Chem Soc 83 (4): 379-386.
30. Paradkar A, Ambike AA, Jadhav BK, Mahadik KR (2004) Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm 271: 281-286.
31. Patel K, Bharatiya B, Kadam Y, Bahadur P (2010) Micellization and clouding behavior of EO-PO block copolymer in aqueous salt aolutions. J Surfactants Deterg 13: 89-95.
32. Sahu A, Kasoju N, Goswami P, Bora U (2011) Encapsulation of curcumin in Pluronic block copolymer micelles for drug delivery applications. J Biomater Appl 25: 619-639.
33. Sezgin Z, Yüksel N, Baykara T (2006) Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm 64: 261-268.
34. Singh R, Tonnesen HH, Vogensen SB, Loftsson T, Masson M (2010) Studies of curcumin and curcuminoids. XXXVI. The stoichiometry and complexation constants of cyclodextrin complexes as determined by the phase-solubility method and UV-Vis titration. J Inclusion Phenom Macrocyclic Chem 66: 335-348.
35. Tomren MA, Másson M, Loftsson T, Tønnesen HH (2007) Studies on curcumin and curcuminoids. XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrins. Int J Pharm 338: 27-34.
36. Tønnesen HH, Karlsen J (1985) Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch 180: 402-404.
37. Tønnesen HH, Karlsen J, van Henegouwen GB (1986) Studies on curcumin and curcuminoids. VIII. Photochemical stability of curcumin. Z Lebensm Unters Forsch 183: 116-122.
38. Tønnesen HH (2002) Studies of curcumin and curcuminoids, XXVIII. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Pharmazie 57: 820-824.
39. Tønnesen HH, Masson M, Loftsson T (2002) Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 244: 127-135.
40. Tønnesen HH (2006) Solubility and stability of curcumin in solutions containing alginate and other viscosity modifying macromolecules. Studies of curcumin and curcuminoids. XXX. Pharmazie 61: 696-700.
41. Yadav VR, Suresh S, Devi K, Yadav S (2009) Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease. J Pharm Pharmacol 61: 311-321.
42. Yallapu MM, Jaggi M, Chauhan SC (2010) beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B 9: 113-125.
43. Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan S (2011) Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 32: 1890-1905.
44. Zhang CX, Zhang J, Li W, Feng X, Hou M, Han B (2008) Formation of micelles of Pluronic block copolymers in PEG 200. J Colloid Interface Sci 327: 157-161.